These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18706057)

  • 21. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Fitzpatrick AE; Noone I; O'Shea DD
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
    [No Abstract]   [Full Text] [Related]  

  • 22. Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.
    Iguchi Y; Kimura K; Shibazaki K; Iwanaga T
    J Neurol Sci; 2009 Apr; 279(1-2):66-9. PubMed ID: 19185882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safer thrombolysis for acute ischemic stroke: is early recanalization the key?
    Tanne D; Levine SR
    Neurology; 2008 Oct; 71(17):1300-1. PubMed ID: 18936422
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intravenous thrombolysis in pediatric arterial ischemic stroke: a case report and a review of the literature].
    Bourdial H; Sassolas F; Ville D; Di Filippo S
    Arch Pediatr; 2008 Oct; 15(10):1541-6. PubMed ID: 18804974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
    Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolytics for hyperacute stroke in children.
    Amlie-Lefond C; Fullerton HJ
    Pediatr Hematol Oncol; 2009; 26(3):103-7. PubMed ID: 19382031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic therapy in cerebral infarction].
    Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
    Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
    Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    Whitcomb DS
    Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing response to thrombolytic therapy.
    Seymour J
    J Lab Clin Med; 1992 Nov; 120(5):801. PubMed ID: 1431510
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
    Tveiten A; Mygland A; Ljøstad U; Thomassen L
    Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NINDS Stroke Trial data reanalysis leaves issues unresolved.
    Smith B
    Stroke; 2005 Mar; 36(3):529-30; author reply 529-30. PubMed ID: 15738576
    [No Abstract]   [Full Text] [Related]  

  • 38. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quicker thrombolytic treatment in stroke?].
    Johnsen SH
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2213. PubMed ID: 19898566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.